awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36866285-04AA413D-F75C-49C2-98D6-A5C0136690A5
Q36866285-04AA413D-F75C-49C2-98D6-A5C0136690A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36866285-04AA413D-F75C-49C2-98D6-A5C0136690A5
Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.
P2860
Q36866285-04AA413D-F75C-49C2-98D6-A5C0136690A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36866285-04AA413D-F75C-49C2-98D6-A5C0136690A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
17e16d80d49a35f2cde8fad5f1db0ca7e5d79b6f
P2860
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.